Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPACK Block for Postoperative Rehabilitation in Total Knee Arthroplasty
NCT06087562Phase 4Unknown
- Sponsor
- Poznan University of Medical Sciences
- Start
- Jun 2020
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Poznan University of Medical Sciences. Primary endpoints: Numerical Rating Scale for Pain at 5 days, Postoperative Opioid Consumption at 96 hours and 1 more. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06087562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06087562.